These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35314202)

  • 1. Enzyme-sensitive nanoparticles, smart TAT and cetuximab conjugated immunoliposomes to overcome multidrug resistance in breast cancer cells.
    Safaei M; Khosravian P; Kazemi Sheykhshabani S; Mardani G; Elahian F; Mirzaei SA
    Toxicol Appl Pharmacol; 2022 Apr; 441():115989. PubMed ID: 35314202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intelligent TAT-coupled anti-HER2 immunoliposomes knock downed MDR1 to produce chemosensitize phenotype of multidrug resistant carcinoma.
    Gholamian Dehkordi N; Elahian F; Khosravian P; Mirzaei SA
    J Cell Physiol; 2019 Nov; 234(11):20769-20778. PubMed ID: 31001890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells.
    Heidari R; Khosravian P; Mirzaei SA; Elahian F
    Sci Rep; 2021 Oct; 11(1):20531. PubMed ID: 34654836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors.
    Yang X; Wang Y; Chen S; Zhang S; Cui C
    Int J Nanomedicine; 2021; 16():7051-7069. PubMed ID: 34703227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty Acid Synthase (FASN) siRNA-Encapsulated-Her-2 Targeted Fab'-Immunoliposomes for Gene Silencing in Breast Cancer Cells.
    Khan A; Aljarbou AN; Aldebasi YH; Allemailem KS; Alsahli MA; Khan S; Alruwetei AM; Khan MA
    Int J Nanomedicine; 2020; 15():5575-5589. PubMed ID: 32801705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells.
    Wang Y; Zhao L; Xiao Q; Jiang L; He M; Bai X; Ma M; Jiao X; Wei M
    Gynecol Oncol; 2016 Jun; 141(3):592-601. PubMed ID: 26644266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells.
    Valinezhad Sani F; Palizban A; Mosaffa F; Jamialahmadi K
    J Pharm Pharmacol; 2021 Jun; 73(7):922-927. PubMed ID: 33885909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells.
    Deng L; Zhang Y; Ma L; Jing X; Ke X; Lian J; Zhao Q; Yan B; Zhang J; Yao J; Chen J
    Int J Nanomedicine; 2013; 8():3271-83. PubMed ID: 24023515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cell adhesion molecule promotes breast cancer resistance protein-mediated multidrug resistance in breast cancer by inducing partial epithelial-mesenchymal transition.
    Shi RZ; He YF; Wen J; Niu YN; Gao Y; Liu LH; Zhang XP; Wang Y; Zhang XL; Zhang HF; Chen M; Hu XL
    Cell Biol Int; 2021 Aug; 45(8):1644-1653. PubMed ID: 33760350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.
    Liu F; Fan D; Qi J; Zhu H; Zhou Y; Yang C; Zhu Z; Xiong D
    Life Sci; 2008 Sep; 83(13-14):496-501. PubMed ID: 18725232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNAs targeting multidrug transporter genes sensitise breast tumour to doxorubicin in a syngeneic mouse model.
    Tiash S; Chowdhury EH
    J Drug Target; 2019 Mar; 27(3):325-337. PubMed ID: 30221549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab Immunoliposomes Enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells.
    Petrilli R; Eloy JO; Lopez RF; Lee RJ
    Anticancer Agents Med Chem; 2017; 17(2):301-308. PubMed ID: 27225449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOPE/CHEMS-Based EGFR-Targeted Immunoliposomes for Docetaxel Delivery: Formulation Development, Physicochemical Characterization and Biological Evaluation on Prostate Cancer Cells.
    Moreira TDS; Silva ADO; Vasconcelos BRF; Santos EDS; de Sousa ACC; de Freitas JVB; de Oliveira YS; Vidal LMT; Ribeiro FOS; de Araújo AR; Vieira Neto JB; Pessoa CDÓ; Petrilli R; Eloy JO
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs.
    Li YT; Chua MJ; Kunnath AP; Chowdhury EH
    Int J Nanomedicine; 2012; 7():2473-81. PubMed ID: 22701315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers.
    Aliabadi HM; Landry B; Mahdipoor P; Hsu CY; Uludağ H
    Eur J Pharm Biopharm; 2012 May; 81(1):33-42. PubMed ID: 22311298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
    Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
    Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
    Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
    J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Talazoparib nanoparticles for overcoming multidrug resistance in triple-negative breast cancer.
    Guney Eskiler G; Cecener G; Egeli U; Tunca B
    J Cell Physiol; 2020 Sep; 235(9):6230-6245. PubMed ID: 32017076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nanostructured lipid-dextran sulfate hybrid carriers overcome tumor multidrug resistance of mitoxantrone hydrochloride.
    Zhang P; Ling G; Pan X; Sun J; Zhang T; Pu X; Yin S; He Z
    Nanomedicine; 2012 Feb; 8(2):185-93. PubMed ID: 21704599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy.
    Dorjsuren B; Chaurasiya B; Ye Z; Liu Y; Li W; Wang C; Shi D; Evans CE; Webster TJ; Shen Y
    Int J Nanomedicine; 2020; 15():8201-8215. PubMed ID: 33122906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.